Charles River Laboratories Share Holder Equity 2010-2024 | CRL

Charles River Laboratories share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Charles River Laboratories share holder equity for the quarter ending December 31, 2024 was $3.467B, a 3.76% decline year-over-year.
  • Charles River Laboratories share holder equity for 2024 was $3.467B, a 3.76% decline from 2023.
  • Charles River Laboratories share holder equity for 2023 was $3.602B, a 20.84% increase from 2022.
  • Charles River Laboratories share holder equity for 2022 was $2.981B, a 17.41% increase from 2021.
Charles River Laboratories Annual Share Holder Equity
(Millions of US $)
2024 $3,467
2023 $3,602
2022 $2,981
2021 $2,539
2020 $2,118
2019 $1,638
2018 $1,320
2017 $1,047
2016 $839
2015 $738
2014 $676
2013 $644
2012 $603
2011 $527
2010 $689
2009 $1,374
Charles River Laboratories Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $3,467
2024-09-30 $3,787
2024-06-30 $3,727
2024-03-31 $3,646
2023-12-31 $3,602
2023-09-30 $3,311
2023-06-30 $3,258
2023-03-31 $3,114
2022-12-31 $2,981
2022-09-30 $2,633
2022-06-30 $2,653
2022-03-31 $2,615
2021-12-31 $2,539
2021-09-30 $2,432
2021-06-30 $2,323
2021-03-31 $2,188
2020-12-31 $2,118
2020-09-30 $1,901
2020-06-30 $1,757
2020-03-31 $1,656
2019-12-31 $1,638
2019-09-30 $1,536
2019-06-30 $1,458
2019-03-31 $1,401
2018-12-31 $1,320
2018-09-30 $1,257
2018-06-30 $1,185
2018-03-31 $1,143
2017-12-31 $1,047
2017-09-30 $1,025
2017-06-30 $966
2017-03-31 $879
2016-12-31 $839
2016-09-30 $873
2016-06-30 $836
2016-03-31 $784
2015-12-31 $738
2015-09-30 $709
2015-06-30 $706
2015-03-31 $668
2014-12-31 $676
2014-09-30 $674
2014-06-30 $675
2014-03-31 $699
2013-12-31 $644
2013-09-30 $659
2013-06-30 $651
2013-03-31 $631
2012-12-31 $603
2012-09-30 $600
2012-06-30 $565
2012-03-31 $555
2011-12-31 $527
2011-09-30 $541
2011-06-30 $591
2011-03-31 $564
2010-12-31 $689
2010-09-30 $1,038
2010-06-30 $1,394
2010-03-31 $1,384
2009-12-31 $1,374
2009-09-30 $1,349
2009-06-30 $1,283
2009-03-31 $1,218
Sector Industry Market Cap Revenue
Medical Medical Services $5.209B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $133.529B 24.94
Elevance Health (ELV) United States $96.108B 12.88
CVS Health (CVS) United States $84.839B 12.41
Cencora (COR) United States $55.604B 20.18
DiDi Global (DIDIY) China $20.317B 29.86
Natera (NTRA) United States $20.018B 0.00
BioMerieux (BMXMF) France $15.594B 0.00
Solventum (SOLV) United States $11.463B 10.69
ICON (ICLR) Ireland $11.251B 10.22
EUROFINS SCIENT (ERFSF) Luxembourg $11.063B 0.00
Revvity (RVTY) United States $11.032B 18.74
CochLear (CHEOY) Australia $10.876B 0.00
Avantor (AVTR) United States $10.289B 15.10
Doximity (DOCS) United States $9.934B 51.66
Viatris (VTRS) United States $9.024B 2.85
Medpace Holdings (MEDP) United States $8.956B 23.46
Sonic Healthcare (SKHHY) Australia $7.706B 0.00
HealthEquity (HQY) United States $7.311B 35.97
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.262B 19.45
Alignment Healthcare (ALHC) United States $3.499B 0.00
Sotera Health (SHC) United States $2.975B 17.18
BrightSpring Health Services (BTSG) United States $2.905B 30.18
Organon (OGN) United States $2.868B 2.92
Surgery Partners (SGRY) United States $2.708B 31.21
GeneDx Holdings (WGS) United States $2.680B 318.23
Concentras Parent (CON) United States $2.613B 13.59
Progyny (PGNY) United States $1.837B 40.45
Ardent Health Partners (ARDT) United States $1.786B 0.00
Premier (PINC) United States $1.765B 11.30
GoodRx Holdings (GDRX) United States $1.720B 37.38
Agilon Health (AGL) United States $1.649B 0.00
PACS (PACS) United States $1.411B 0.00
Teladoc Health (TDOC) United States $1.197B 0.00
Pediatrix Medical (MD) United States $1.100B 9.22
Ryman Healthcare (RYHTY) New Zealand $1.035B 0.00
CareDx (CDNA) United States $0.977B 16.62
Establishment Labs Holdings (ESTA) $0.907B 0.00
Nutex Health (NUTX) United States $0.824B 16.14
AMN Healthcare Services Inc (AMN) United States $0.706B 5.59
Embecta (EMBC) United States $0.659B 4.52
Auna S.A (AUNA) Luxembourg $0.515B 13.65
QDM (QDMI) Hong Kong, SAR China $0.496B 0.00
SBC Medicals (SBC) United States $0.417B 0.00
Sonida Senior Living (SNDA) United States $0.405B 0.00
Enhabit (EHAB) United States $0.388B 36.57
InnovAge Holding (INNV) United States $0.372B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.290B 0.00
LifeMD (LFMD) United States $0.242B 0.00
DocGo (DCGO) United States $0.216B 8.83
Performant Healthcare (PHLT) United States $0.195B 0.00
Oncology Institute (TOI) United States $0.163B 0.00
Sera Prognostics (SERA) United States $0.128B 0.00
Beauty Health (SKIN) United States $0.106B 0.00
So-Young (SY) China $0.084B 0.00
Basel Medical Group (BMGL) Singapore $0.082B 0.00
OncoCyte (OCX) United States $0.081B 0.00
Biodesix (BDSX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.018B 0.00
ModivCare (MODV) United States $0.014B 4.93
Co-Diagnostics (CODX) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
Aclarion (ACON) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00